Experienced in Angiosarcoma of the Liver

Xiaoqing F. Jiang

No. 225 Changhai Road, 
Shanghai, CN 
Experienced in Angiosarcoma of the Liver
No. 225 Changhai Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Xiaoqing Jiang practices in Shanghai, China. Jiang is rated as an Experienced expert by MediFind in the treatment of Angiosarcoma of the Liver. Their top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Gallbladder Disease, Hepatectomy, and Pancreaticoduodenectomy.

Their clinical research consists of co-authoring 118 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Angiosarcoma of the Liver.

Locations

No. 225 Changhai Road, Shanghai, 200438, China
Other Locations
No. 242, Guangji Road, Suzhou, 215002, China
No.225, Changhai Road, Yangpu, 200433, China
225 Changhai Rd, Yangpu, China
Chang Hai Road 225, Shanghai, 200438, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Multi-center, Randomized, Controlled, Open-label Study of Deuteporfin Photodynamic Therapy Plus Stenting Versus Stenting Alone as Treatment for Unresectable Advanced Perihilar Cholangiocarcinoma
Multi-center, Randomized, Controlled, Open-label Study of Deuteporfin Photodynamic Therapy Plus Stenting Versus Stenting Alone as Treatment for Unresectable Advanced Perihilar Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: July 17, 2019
Intervention Type: Combination product, Device
Study Phase: Phase 2

118 Total Publications

Targeting EGFR-Mcl-1 Axis by Piperlongumine as a Novel Strategy for Non-Small Cell Lung Cancer Therapy.
Targeting EGFR-Mcl-1 Axis by Piperlongumine as a Novel Strategy for Non-Small Cell Lung Cancer Therapy.
Journal: The American journal of Chinese medicine
Published: March 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Jiang's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile